Cite
HARVARD Citation
Gomez-Mancilla, B. et al. (2014). Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. Cephalalgia. pp. 103-113. [Online].